Morningstar

Star Copper Reports Balance of Phase 1 Drill Results Extending Supergene Zone Southwest

VANCOUVER, BC / ACCESS Newswire / January 13, 2026 / Star Copper Corp. (CSE:STCU)(OTCQX:STCUF)(FWB:SOP) ("Star Copper" or the "Company"), a critical minerals exploration and development company, is ...
Seeking Alpha

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome

– Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction in acute pancreatitis events – – Results ...
Nasdaq

Crinetics Doses First Patient In Phase 2/3 BALANCE-CAH Trial Of Atumelnant

(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) has dosed the first patient in its Phase 2/3 trial of investigational drug Atumelnant for the treatment of classic congenital adrenal hyperplasia in ...
Business Wire

Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology ...

BALANCE is a Phase 1/2, first-in-disease dose escalation and expansion study of ALPN-101 in patients with active, steroid-refractory or steroid-resistant acute GVHD. It will explore the safety, ...
The Manila Times

Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 million ...